• Anti Reverse Cap Analog: From Cap to Translation

  2026-09-30

  A translational guide to how Anti Reverse Cap Analog (ARCA), 3´-O-Me-m7G(5')ppp(5')G, can help researchers control mRNA cap orientation, translation initiation, and experimental reproducibility while interpreting emerging mRNA delivery studies with appropriate caution.

• BAY-826 in Tie-2–PEDF Retinal Assays

  2026-09-30

  BAY-826 is a potent small molecule inhibitor for dissecting angiopoietin-linked neurovascular signaling. This guide translates Müller cell and PEDF findings into practical assay design, controls, handling decisions, and interpretation limits.

• Lisinopril Dihydrate: From ACE Inhibition to Translation

  2026-09-29

  Lisinopril dihydrate offers a mechanistically interpretable way to interrogate the renin–angiotensin system across hypertension research, heart failure research, acute myocardial infarction research, and diabetic nephropathy models. This thought-leadership guide connects nanomolar ACE inhibition with assay design, comparator selection, and translational decision-making.

• LMO2–LDB1 Signaling in Acute Myeloid Leukemia

  2026-09-29

  The reference study defines an LMO2/LDB1 protein complex as a functional driver of acute myeloid leukemia (AML), rather than treating LMO2 only as a prognostic marker. By combining genetic perturbation, protein-interaction analysis, rescue experiments, and transcriptomic and chromatin profiling, it connects this complex to AML cell survival, proliferation, colony formation, and apoptosis-related gene regulation.

• Angiotensin 1/2 (1-6): Assay Strategy

  2026-09-28

  Explore how Angiotensin 1/2 (1-6), the Asp-Arg-Val-Tyr-Ile-His hexapeptide, can be used to design more discriminating renin-angiotensin system and receptor-binding studies. This guide translates recent spike–AXL binding findings into practical assay controls while separating biochemical evidence from physiological interpretation.

• Diminazene Aceturate in ACE2 and Parasite Research

  2026-09-28

  Diminazene Aceturate offers a useful research bridge between trypanocidal assays and investigation of ACE2-associated cardiac protection—but those are distinct experimental questions. This guide turns the reported sepsis-cardiomyopathy findings into a practical workflow, with formulation checks, assay choices, and controls that help separate pathway evidence from compound effects.

• Diminazene Aceturate: Practical Research Workflows

  2026-09-27

  Diminazene Aceturate offers a useful experimental bridge between trypanosome parasite research and investigations of ACE2-linked cardiac biology—but those applications require separate controls and cautious interpretation. This workflow guide turns the February 2024 sepsis-cardiomyopathy findings into practical assay choices, handling steps, and troubleshooting checks without treating preclinical results as clinical evidence.

• Gastrodin, Microglia, and Astrocyte RAS–SIRT3

  2026-09-26

  A 2024 study used microglial conditioned medium and AT1-receptor inhibition to examine how gastrodin alters renin–angiotensin system (RAS) and inflammatory markers in reactive astrocytes. The results connect microglia-to-astrocyte signaling with RAS–SIRT3 regulation, while leaving important questions about pathway causality and in vivo relevance open.

• GPR107 Loss Promotes Diabetic Nephropathy

  2026-09-25

  Xu et al. report that GPR107 deficiency worsens diabetic kidney injury by impairing clathrin-mediated internalization of AT1R in podocytes, shifting collagen IV production and degradation toward extracellular accumulation. The findings connect receptor trafficking to glomerular basement membrane remodeling and suggest a mechanism to test in future diabetic nephropathy research.

• Losartan Beyond Blood Pressure: Testing Matrix Biology

  2026-09-25

  Losartan is more than an angiotensin II receptor antagonist for hypertension research: its use in a tumor hydrogel study raises new questions about how to measure extracellular-matrix remodeling. Explore the study’s practical assay implications, experimental limits, and ways to interpret Losartan’s effects across cardiovascular and tumor biology.

• Dexamethasone Workflows for Inflammation Research

  2026-09-24

  Build more interpretable inflammation assays with practical Dexamethasone treatment, vehicle-control, and readout strategies. The workflow connects glucocorticoid signaling studies with a recent natural-product macrophage study—while keeping their evidence and potency claims distinct.

• Angiotensin III: Practical RAAS Assay Workflows

  2026-09-24

  Use Angiotensin III to probe aldosterone release, receptor signaling, and a newly reported angiotensin-peptide effect on spike–receptor binding. This workflow-oriented guide separates established RAAS biology from exploratory assay recommendations and shows how to handle the peptide for reproducible results.

• Acetylcholine Chloride for Reproducible Assays

  2026-09-23

  Learn how to use Acetylcholine Chloride (SKU B1596) as a controlled cholinergic stimulus in cell-based and neuroscience workflows without confusing receptor activation with a viability readout. Practical guidance covers experimental controls, handling, interpretation of gut–brain findings, and product selection.

• JNJ-26481585 (Quisinostat) Research Workflows

  2026-09-23

  Learn how to deploy JNJ-26481585 (Quisinostat) as an epigenetic modulator for apoptosis, proliferation, and drug-resistance studies. This workflow connects HDAC inhibition with the TRIM21–ERK1/2 axis while emphasizing assay controls, formulation, and troubleshooting.

• SU6656: From Src Biology to Translational Strategy

  2026-09-22

  SU6656 is more than a catalog-listed Src tyrosine kinases inhibitor: it is a mechanistic probe connecting Src-regulated proliferation, megakaryocyte polyploidization, endothelial survival, and tumor vascular response. This thought-leadership article translates the available evidence into a disciplined framework for platelet-production research, cancer research, and radiotherapy development while distinguishing validated findings from forward-looking experimental opportunities.

7777 records 1/519 page Next 12345 下5页 Last page